| Dr James N Reich, MD | |
|
1150 N 35th Ave, Suite 620, Hollywood, FL 33021-5424 | |
| (954) 989-9553 | |
| (954) 989-9607 |
| Full Name | Dr James N Reich |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 27 Years |
| Location | 1150 N 35th Ave, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467556795 | NPI | - | NPPES |
| 1821104084 | Other | GROUP NPI | |
| 17394 | Other | FL | BCBS |
| 1467556795 | Other | NPI | |
| 264086400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 82676 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pembroke Pines Dialysis | Pembroke pines, FL | Dialysis facility |
| South Broward Artificial Kidney Ctr | Hollywood, FL | Dialysis facility |
| South Florida Dialysis | Hollywood, FL | Dialysis facility |
| Embassy Lakes Artificial Kidney Center | Cooper city, FL | Dialysis facility |
| Memorial Regional Hospital | Hollywood, FL | Hospital |
| Memorial Hospital West | Pembroke pines, FL | Hospital |
| Memorial Hospital Pembroke | Pembroke pines, FL | Hospital |
| Memorial Hospital Miramar | Miramar, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Florida Kidney Physicians Llc | 4385925650 | 140 |
News Archive
Although Alzheimer's disease (AD) impacts more than five million Americans and 15 million caregivers year-round, the nation is especially focused on the disease this month as it observes "National Alzheimer's Disease and Awareness Month."
Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
Sound Physicians, a physician-founded and led organization with more than 2,000 physicians providing care in more than 300 hospitals and post-acute facilities across the U.S., announced today it has honored St. Alphonsus Medical Center in Nampa, Idaho, with its Symphony Award, given to the hospitalist team with the highest overall internally measured, standardized and benchmarked performance scores out of all Sound Physicians' hospitalist and intensivist programs nationwide.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
› Verified 4 days ago
| Entity Name | Alberto Casaretto Md Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306939327 PECOS PAC ID: 6103884820 Enrollment ID: O20041228000920 |
News Archive
Although Alzheimer's disease (AD) impacts more than five million Americans and 15 million caregivers year-round, the nation is especially focused on the disease this month as it observes "National Alzheimer's Disease and Awareness Month."
Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
Sound Physicians, a physician-founded and led organization with more than 2,000 physicians providing care in more than 300 hospitals and post-acute facilities across the U.S., announced today it has honored St. Alphonsus Medical Center in Nampa, Idaho, with its Symphony Award, given to the hospitalist team with the highest overall internally measured, standardized and benchmarked performance scores out of all Sound Physicians' hospitalist and intensivist programs nationwide.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
› Verified 4 days ago
| Entity Name | Florida Kidney Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760831564 PECOS PAC ID: 4385925650 Enrollment ID: O20161228000460 |
News Archive
Although Alzheimer's disease (AD) impacts more than five million Americans and 15 million caregivers year-round, the nation is especially focused on the disease this month as it observes "National Alzheimer's Disease and Awareness Month."
Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
Sound Physicians, a physician-founded and led organization with more than 2,000 physicians providing care in more than 300 hospitals and post-acute facilities across the U.S., announced today it has honored St. Alphonsus Medical Center in Nampa, Idaho, with its Symphony Award, given to the hospitalist team with the highest overall internally measured, standardized and benchmarked performance scores out of all Sound Physicians' hospitalist and intensivist programs nationwide.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James N Reich, MD 1150 N 35th Ave, Suite 620, Hollywood, FL 33021-5424 Ph: (954) 989-9553 | Dr James N Reich, MD 1150 N 35th Ave, Suite 620, Hollywood, FL 33021-5424 Ph: (954) 989-9553 |
News Archive
Although Alzheimer's disease (AD) impacts more than five million Americans and 15 million caregivers year-round, the nation is especially focused on the disease this month as it observes "National Alzheimer's Disease and Awareness Month."
Developing a simple, paper-based test for drug-resistant tuberculosis (TB) is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
Sound Physicians, a physician-founded and led organization with more than 2,000 physicians providing care in more than 300 hospitals and post-acute facilities across the U.S., announced today it has honored St. Alphonsus Medical Center in Nampa, Idaho, with its Symphony Award, given to the hospitalist team with the highest overall internally measured, standardized and benchmarked performance scores out of all Sound Physicians' hospitalist and intensivist programs nationwide.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the U.S. Food and Drug Administration has issued 510(k) clearance to the Simplexa Influenza A H1N1 (2009) test on the 3M Integrated Cycler. The Simplexa test, developed and manufactured by Quest Diagnostics' Focus Diagnostics business, is the first to be cleared by the FDA for use as an aid in the detection and differentiation of influenza A and 2009 H1N1 influenza viral RNA.
› Verified 4 days ago
Dr. David Lee Arnold, DO Nephrology Medicare: Medicare Enrolled Practice Location: 1701 Fletcher St, Hollywood, FL 33020 Phone: 208-841-4552 | |
Dr. Hugo Victor Bejar, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 795 S Federal Hwy, Hollywood, FL 33020 Phone: 954-923-4646 | |
Dr. Juan Carlos Brenes, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave Ste 605, Hollywood, FL 33021 Phone: 954-265-7900 Fax: 954-276-0271 | |
Dr. Wayne Brett Schonfeld, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4700 Sheridan St, Suite F, Hollywood, FL 33021 Phone: 954-961-8400 Fax: 954-963-8508 | |
Michael S Marek, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3702 Washington St, Suite 303, Hollywood, FL 33021 Phone: 954-967-6550 Fax: 954-967-6553 | |
Larrye Michael Feldman, DO Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3389 Sheridan St, Box #204, Hollywood, FL 33021 Phone: 954-240-0813 | |
Lawrence Michael Reiss, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave, Suite 605, Hollywood, FL 33021 Phone: 954-265-7900 Fax: 954-276-0264 |